FI961004A - Määrityspakkaus - Google Patents

Määrityspakkaus Download PDF

Info

Publication number
FI961004A
FI961004A FI961004A FI961004A FI961004A FI 961004 A FI961004 A FI 961004A FI 961004 A FI961004 A FI 961004A FI 961004 A FI961004 A FI 961004A FI 961004 A FI961004 A FI 961004A
Authority
FI
Finland
Prior art keywords
binding
immunophilin
competitor
pharmaceutical
compounds
Prior art date
Application number
FI961004A
Other languages
English (en)
Swedish (sv)
Other versions
FI961004A0 (fi
FI111035B (fi
Inventor
Francois Legay
Roland Wenger
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of FI961004A0 publication Critical patent/FI961004A0/fi
Publication of FI961004A publication Critical patent/FI961004A/fi
Application granted granted Critical
Publication of FI111035B publication Critical patent/FI111035B/fi

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9493Immunosupressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Input Circuits Of Receivers And Coupling Of Receivers And Audio Equipment (AREA)
  • Saccharide Compounds (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fishing Rods (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Sanitary Device For Flush Toilet (AREA)
  • Investigation Of Foundation Soil And Reinforcement Of Foundation Soil By Compacting Or Drainage (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI961004A 1993-09-08 1996-03-04 Määritysmenetelmä ja määrityspakkaus FI111035B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9318612 1993-09-08
GB939318612A GB9318612D0 (en) 1993-09-08 1993-09-08 An assay
EP9402986 1994-09-07
PCT/EP1994/002986 WO1995007468A1 (en) 1993-09-08 1994-09-07 Assay kit

Publications (3)

Publication Number Publication Date
FI961004A0 FI961004A0 (fi) 1996-03-04
FI961004A true FI961004A (fi) 1996-03-04
FI111035B FI111035B (fi) 2003-05-15

Family

ID=10741695

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961004A FI111035B (fi) 1993-09-08 1996-03-04 Määritysmenetelmä ja määrityspakkaus

Country Status (23)

Country Link
EP (1) EP0717850B1 (fi)
JP (1) JP2892503B2 (fi)
KR (1) KR100313841B1 (fi)
CN (1) CN1088196C (fi)
AT (1) ATE153769T1 (fi)
AU (1) AU680946B2 (fi)
BR (1) BR9407422A (fi)
CA (1) CA2169162C (fi)
CZ (1) CZ289434B6 (fi)
DE (1) DE69403484T2 (fi)
DK (1) DK0717850T3 (fi)
ES (1) ES2103136T3 (fi)
FI (1) FI111035B (fi)
GB (1) GB9318612D0 (fi)
GR (1) GR3023578T3 (fi)
HK (1) HK1005754A1 (fi)
HU (1) HU218743B (fi)
NO (1) NO960924D0 (fi)
NZ (1) NZ273595A (fi)
PL (1) PL176727B1 (fi)
RU (1) RU2138052C1 (fi)
SK (1) SK281369B6 (fi)
WO (1) WO1995007468A1 (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
US5650288A (en) * 1995-07-14 1997-07-22 Macfarlane; Gordon D. Immunophilin-bound immunosuppressant assay
WO1997033604A1 (en) * 1996-03-12 1997-09-18 Picower Institute For Medical Research Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity
US6106779A (en) * 1997-10-02 2000-08-22 Biosite Diagnostics, Inc. Lysis chamber for use in an assay device
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
ATE264863T1 (de) 1999-08-24 2004-05-15 Ariad Gene Therapeutics Inc 28-epirapaloge
DE60331367D1 (de) 2002-12-30 2010-04-01 Angiotech Int Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
US7186518B2 (en) 2003-11-21 2007-03-06 Dade Behring Inc. Method and composition useful for determining FK 506
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
KR20080033274A (ko) 2005-06-17 2008-04-16 노파르티스 아게 Hcv에서 상글리페린의 용도
CN100434901C (zh) * 2006-01-12 2008-11-19 上海交通大学 血红蛋白凝胶层析的教学试剂盒
US7914999B2 (en) * 2006-12-29 2011-03-29 Abbott Laboratories Non-denaturing lysis reagent
US7790401B2 (en) * 2007-08-06 2010-09-07 Siemens Healthcare Diagnostics Methods for detection of immunosuppressant drugs
CA2711765A1 (en) 2008-01-11 2009-07-16 Massachusetts Eye & Ear Infirmary Conditional-stop dimerizable caspase transgenic animals
US9658218B2 (en) * 2012-05-07 2017-05-23 Siemens Healthcare Diagnostics Inc. Determination of total analyte concentration
US9121859B2 (en) * 2012-12-04 2015-09-01 Siemens Healthcare Diagnostics Inc. Compounds and methods for determination of FKBP-binding immunosuppressant drugs
CN105283553B (zh) 2013-06-11 2021-06-25 克隆技术实验室有限公司 蛋白质富集的微泡及其制备和使用方法
KR101760707B1 (ko) 2015-01-05 2017-07-24 한림대학교 산학협력단 이종 알부민을 이용한 장기 이식 거부반응 검사용 키트
CN104749009B (zh) * 2015-03-30 2018-05-04 上海云泽生物科技有限公司 用于免疫分析的免疫抑制剂药物提取试剂
CN104764883A (zh) * 2015-03-31 2015-07-08 上海云泽生物科技有限公司 一种检测环孢霉素a浓度的免疫分析方法和试剂盒
EP3873509B1 (en) * 2018-11-02 2024-06-12 Siemens Healthcare Diagnostics, Inc. Binding competitors for use in macrophilin-binding pharmaceutical assays and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293892B1 (en) * 1987-06-05 1993-12-15 Fujisawa Pharmaceutical Co., Ltd. Anti-FR-900506 substance antibodies and highly-sensitive enzyme immunoassay method
ES2059558T3 (es) * 1987-06-17 1994-11-16 Sandoz Ag Ciclosporins y su uso como productos farmaceuticos.
US5322772A (en) * 1991-04-09 1994-06-21 Children's Research Institute Rapamycin assay
AU4400593A (en) * 1992-06-05 1994-01-04 Abbott Laboratories Methods and reagents for the determination of immunosuppressive agents
GB9307491D0 (en) * 1993-04-08 1993-06-02 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
CN1130425A (zh) 1996-09-04
DE69403484T2 (de) 1997-12-04
AU680946B2 (en) 1997-08-14
AU7694894A (en) 1995-03-27
ES2103136T3 (es) 1997-08-16
PL176727B1 (pl) 1999-07-30
EP0717850A1 (en) 1996-06-26
JPH09502272A (ja) 1997-03-04
HK1005754A1 (en) 1999-01-22
RU2138052C1 (ru) 1999-09-20
SK281369B6 (sk) 2001-02-12
CZ66296A3 (en) 1996-09-11
CN1088196C (zh) 2002-07-24
HU9600564D0 (en) 1996-05-28
SK31096A3 (en) 1996-07-03
FI961004A0 (fi) 1996-03-04
DK0717850T3 (da) 1997-10-20
CA2169162C (en) 2004-02-03
FI111035B (fi) 2003-05-15
ATE153769T1 (de) 1997-06-15
DE69403484D1 (de) 1997-07-03
PL313392A1 (en) 1996-06-24
NZ273595A (en) 1996-08-27
JP2892503B2 (ja) 1999-05-17
NO960924L (no) 1996-03-07
KR100313841B1 (ko) 2001-12-28
NO960924D0 (no) 1996-03-07
GB9318612D0 (en) 1993-10-27
BR9407422A (pt) 1996-04-09
CZ289434B6 (cs) 2002-01-16
GR3023578T3 (en) 1997-08-29
HUT73692A (en) 1996-09-30
EP0717850B1 (en) 1997-05-28
HU218743B (hu) 2000-11-28
WO1995007468A1 (en) 1995-03-16
CA2169162A1 (en) 1995-03-16

Similar Documents

Publication Publication Date Title
DK0717850T3 (da) Assaykit
ES2293973T3 (es) Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos.
BRPI0607486A2 (pt) anticorpo l243 humanizado, anticorpo biespecìfico ou fragmentos de ligação a antìgeno dos mesmos, composição farmacêutica, kit e uso dos referidos anticorpos
WO2002020569A3 (en) Mammalian genes; related reagents and methods
NO20025354L (no) Pattedyr-reseptorproteiner; beslektede reagenser og fremgangsmåter
DE69230146T2 (de) Monoklonale antikörper gegen putative hcv-e2/ns1-proteine und verfahren zu ihrer verwendung
WO2001090358A3 (en) Mammalian receptor proteins; related reagents and methods
RU96107464A (ru) Аналитический набор
ATE395364T1 (de) Gegen procalcitonin gerichtete antikörper, ihre herstellung und verwendung
DE69610716D1 (de) Topiramate-immunoassay, sowie analoge und antikörper
DK1692181T3 (da) Leptinantagonist og fremgangsmåde til kvantitativ måling af leptin
BR0113213A (pt) Método para diagnosticar uma doença auto-imune, anticorpo, composição de diagnóstico, e, uso do anticorpo
WO2001036467A3 (en) Mammalian receptor proteins; related reagents and methods
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
DK0725837T3 (da) Adeno-associeret virus - dettes diagnostiske anvendelse ved tidlig abort
DK1181366T3 (da) Mammale receptorproteiner, beslægtede reagenser og fremgangsmåder
DK26587A (da) Monoklonalt antistof, maalemetode for glucosyleret protein ved anvendelse af det monoklonale antistofog kit omfattende dette
Thacker et al. Immunoassays (ELISA) for rapid, quantitative analysis in the food-processing industry
CA2419046A1 (en) Method for detecting or measuring hbv
WO2005065711A3 (en) Mammalian receptor proteins; related reagents and methods
DK1171157T3 (da) Anvendelse af glucose-6-phosphat-isomerase og antistoffer derimod til diagnosticering og behandling af arthritis, og test for anti-arthritis-forbindelser
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
EP2698383A1 (en) Detection of synthetic Cannabinoids
ATE305969T1 (de) Probengeber für massenspektrometrie
DK1161522T3 (da) Fremgangsmåde til isolering af CD8+-celler og beslægtede hybridomaceller, antistoffer og polypeptider

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

MA Patent expired